·Confidence 85%
AI-Designed Drug Shows Promise in Reversing Biological Aging
Insilico Medicine's AI-engineered drug rentosertib demonstrates significant biological age reduction in patients, advancing to Phase III trials for IPF
#healthcare
8 articles tagged with #healthcare
·Confidence 80%
Chip Shortage Impacts AI Progress in Cancer Research
Arm's CEO highlights how the ongoing chip shortage is delaying AI advancements in cancer research, potentially hindering treatment breakthroughs.
·Confidence 90%
DOJ Reaches Settlement with Mount Sinai on Pediatric Care
The DOJ has settled with Mount Sinai, ending pediatric gender transition procedures and mandating $2 million for restorative care for affected individuals.
·Confidence 90%
Subsense Secures $27M for Innovative Brain-Computer Interface
Subsense has raised $27 million to develop a nanoparticle-based brain-computer interface, potentially transforming treatments for neurological disorders.
·Confidence 80%
Cigna anticipates $200 million savings from AI health tools
Cigna expects to save $200 million over three years through AI-driven predictive health tools, potentially transforming healthcare cost management and disease
·Confidence 80%
Abbott Introduces AI Tool Libre Assist for Diabetes Management
Abbott's new AI-powered tool, Libre Assist, aims to enhance diabetes management by influencing dietary choices and improving patient outcomes.
·Confidence 90%
Trump Signs Order to Space Out Childhood Vaccines
President Trump has signed an executive order on Aug. 10 advocating for spacing out childhood vaccines, raising public health concerns about potential delays.
·Confidence 75%
Bank of America Allocates $250 Million for GLP-1 Drugs
Bank of America CEO reveals the bank spends $250 million annually on GLP-1 drugs for employees, highlighting rising demand for treatments like Ozempic and